Arch Therapeutics Inc (ARTH)

[Regis999]

Thanks. I saw that but will any doctor use without human or even animal data?? Doctors rely on human data and who better to communicate than a major supplier.

BTW the market cap of 3D Matrix was $ 197 million versus Arcg's approximately $ 50 million. The only thing they have done right in past is raising capital.

Arch's flaw which has worked to our benefit is they formed as a reverse merger in 2013. They should have done a straight IPO and raised ALL the capital they needed for Europe and USA human trials--approximately $ 20 million. When they did the reverse merger they issued 3 for 1 warrants expecting exercise at higher prices. Well stock went down not up and they had to adjust the exercise price of the warrants. The exercise of these warrants have helped finance Arch.

Right now per public filings needs $ 10 to $ 14 million to complete Europe and USA human trials. This is tiny in the biotech world. BTW Arch has raised approximately $ 13 million since the reverse merger in 2013.

So we have a CEO who is a MD, MIT MBA adn and Former Portfolio Manager at Putnam $4 Billion Healthcare Fund. He has stated he teaches diversification but has all his eggs in Arch. He has been building Arch since 2006. Public in 2013. He owns approximately 15 million shares and options of Arch. He is very very driven. He is also a great speaker. Watch some of his videos:

Company Video

Finally a scientist has called Arch's family of peptides which I discussed yesterday among the most remarkable biochemical inventions of all time. The reason for this is what I discussed yesterday.